Cargando…

Enzymatic remodeling of heparan sulfate: a therapeutic strategy for systemic and localized amyloidoses?

Detalles Bibliográficos
Autores principales:	Nishitsuji, Kazuchika, Saito, Hiroyuki, Uchimura, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828998/ https://www.ncbi.nlm.nih.gov/pubmed/27127472 http://dx.doi.org/10.4103/1673-5374.179043

Ejemplares similares

Design and Synthesis of 6‐O‐Phosphorylated Heparan Sulfate Oligosaccharides to Inhibit Amyloid β Aggregation
por: Uchimura, Kenji, et al.
Publicado: (2022)

Beta3Gn-T7 Is a Keratan Sulfate β1,3 N-Acetylglucosaminyltransferase in the Adult Brain
por: Takeda-Uchimura, Yoshiko, et al.
Publicado: (2022)

Heparan sulfate proteoglycans and heparanases in Alzheimer's disease: current outlook and potential therapeutic targets
por: Lorente-Gea, Laura, et al.
Publicado: (2017)

Heparan sulfate proteoglycans as possible diagnostic molecular tools with therapeutic potential in Alzheimer´s disease
por: Fernández-Vega, Iván, et al.
Publicado: (2020)

Complementary Role of GlcNAc6ST2 and GlcNAc6ST3 in Synthesis of CL40-Reactive Sialylated and Sulfated Glycans in the Mouse Pleural Mesothelium
por: Takeda-Uchimura, Yoshiko, et al.
Publicado: (2022)

Systemic amyloidoses and proteomics: The state of the art
por: Lavatelli, Francesca, et al.
Publicado: (2016)

Advances in diagnostics and therapy of systemic amyloidoses
por: Jamroziak, Krzysztof, et al.
Publicado: (2020)

Treating Protein Misfolding Diseases: Therapeutic Successes Against Systemic Amyloidoses
por: Nevone, Alice, et al.
Publicado: (2020)

Heparan sulfates and heparan sulfate binding proteins in sepsis
por: Liao, Yi-En, et al.
Publicado: (2023)

Iowa Mutant Apolipoprotein A-I (ApoA-I(Iowa)) Fibrils Target Lysosomes
por: Kameyama, Hirokazu, et al.
Publicado: (2016)

Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses
por: De Pasquale, Valeria, et al.
Publicado: (2018)

Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
por: Nagarajan, Arvindhan, et al.
Publicado: (2018)

Oxidative Stress, Chronic Inflammation, and Amyloidoses
por: Orzechowski, Arkadiusz, et al.
Publicado: (2019)

Amyloïdose induite par l’insuline
por: Kano, Yasuhiro
Publicado: (2023)

Differential structural remodelling of heparan sulfate by chemokines: the role of chemokine oligomerization
por: Dyer, Douglas P., et al.
Publicado: (2017)

Stress Response Is the Main Trigger of Sporadic Amyloidoses
por: Galkin, Alexey P., et al.
Publicado: (2021)

Structure of Tau filaments in Prion protein amyloidoses
por: Hallinan, Grace I., et al.
Publicado: (2021)

Kardiale Amyloidose: Aktuelle und zukünftige Therapieoptionen
por: Knoll, Katharina, et al.
Publicado: (2023)

Heparan Sulfate Regrowth Profiles Under Laminar Shear Flow Following Enzymatic Degradation
por: Giantsos-Adams, Kristina M., et al.
Publicado: (2013)

Dexamethasone Inhibits Heparan Sulfate Biosynthetic System and Decreases Heparan Sulfate Content in Orthotopic Glioblastoma Tumors in Mice
por: Sokolov, Dmitry K., et al.
Publicado: (2023)

Combinatorial Roles of Heparan Sulfate Proteoglycans and Heparan Sulfates in Caenorhabditis elegans Neural Development
por: Kinnunen, Tarja K.
Publicado: (2014)

DES-Amyloidoses “Amyloidoses through the looking-glass”: A knowledgebase developed for exploring and linking information related to human amyloid-related diseases
por: Bajic, Vladan P., et al.
Publicado: (2022)

Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers
por: Hull, Elizabeth E., et al.
Publicado: (2017)

Heparan sulfate gets specific
por: Dove, Alan W.
Publicado: (2001)

Heparan sulfate proteoglycans and cancer
por: Blackhall, F H, et al.
Publicado: (2001)

Heparan Sulfate Proteoglycans in Infection
por: Bartlett, Allison H., et al.
Publicado: (2011)

Heparan Sulfate Proteoglycans in Tauopathy
por: Zhu, Yanan, et al.
Publicado: (2022)

Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse
por: Chen, Jihuan, et al.
Publicado: (2017)

A dominant negative splice variant of the heparan sulfate biosynthesis enzyme NDST1 reduces heparan sulfate sulfation
por: Missaghian, Parisa, et al.
Publicado: (2022)

QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling
por: Ai, Xingbin, et al.
Publicado: (2003)

Heparan Sulfate as a Therapeutic Target in Tauopathies: Insights From Zebrafish
por: Alavi Naini, Seyedeh Maryam, et al.
Publicado: (2018)

Amyloïdose féline à expression hépatique chez 2 chats()
por: Derré, G., et al.
Publicado: (2014)

Diversity of Heparan Sulfate and HSV Entry: Basic Understanding and Treatment Strategies
por: Tiwari, Vaibhav, et al.
Publicado: (2015)

Antiviral strategies should focus on stimulating the biosynthesis of heparan sulfates, not their inhibition
por: Cheudjeu, Antony
Publicado: (2021)

Divergent Synthesis of Heparan Sulfate Oligosaccharides
por: Dulaney, Steven B., et al.
Publicado: (2015)

Heparan sulfate is essential for thymus growth
por: Hsu, Hsuan-Po, et al.
Publicado: (2021)

The neutralization of heparan sulfate by heparin-binding copolymer as a potential therapeutic target
por: Kalaska, Bartlomiej, et al.
Publicado: (2019)

Serum heparan sulfate levels are elevated in endotoxemia
por: Hofmann-Kiefer, KF, et al.
Publicado: (2009)

Heparan Sulfate Biosynthesis: Methods for Investigation of the Heparanosome
por: Multhaupt, Hinke A. B., et al.
Publicado: (2012)

Heparan Sulfate-Dependent Enhancement of Henipavirus Infection
por: Mathieu, Cyrille, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2r7f923jfehdo3tapsiigmp24d